Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
27 hedge funds and large institutions have $5.65M invested in Renalytix plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 9 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
13% less funds holding
Funds holding: 31 → 27 (-4)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
59% less capital invested
Capital invested by funds: $13.9M → $5.65M (-$8.28M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $41K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$1.02M |
| 2 |
Renaissance Technologies
New York
|
+$274K |
| 3 |
Millennium Management
New York
|
+$249K |
| 4 |
PA
Pinnacle Associates
New York
|
+$246K |
| 5 |
Two Sigma Investments
New York
|
+$75.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Philosophy Capital Management
Alamo,
California
|
-$2.1M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$811K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$794K |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$607K |
| 5 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$460K |
RNLX Hedge Fund Activity: Q3 2022 in Review
27 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q3 2022, worth a combined $5.65M — down 59% from $13.9M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of RNLX and 5 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 12 added.
The largest buyer was Pentwater Capital Management, adding an estimated $1.02M. The largest seller was Philosophy Capital Management, exiting entirely with an estimated $2.1M sold.
- 27 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q3 2022, down from 31 in Q2 2022.
- Funds reported $5.65M of Renalytix plc American Depositary Shares stock for Q3 2022, down 59% quarter-over-quarter.
- 5 funds opened new Renalytix plc American Depositary Shares positions in Q3 2022 and 9 closed out, a net change of -4 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q3 2022 was Pentwater Capital Management, an estimated $1.02M added.
- The largest Renalytix plc American Depositary Shares seller in Q3 2022 was Philosophy Capital Management, an estimated $2.1M sold.
Based on aggregated 13F filings for Q3 2022.